aXichem AB (AXIC-A) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.034x

Based on the latest financial reports, aXichem AB (AXIC-A) has a cash flow conversion efficiency ratio of -0.034x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr-1.98 Million ≈ $-213.40K USD) by net assets (Skr58.07 Million ≈ $6.25 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See defensive interval ratio of aXichem AB to measure how many days the company can operate on defensive assets alone.

aXichem AB - Cash Flow Conversion Efficiency Trend (2008–2024)

This chart illustrates how aXichem AB's cash flow conversion efficiency has evolved over time, based on yearly financial data.

aXichem AB Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of aXichem AB ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Target Healthcare REIT Ltd
LSE:THRL
0.033x
Golden Pharos Bhd
KLSE:5649
-0.057x
ALERIO GOLD CORP.
F:3FR0
N/A
California Nanotechnologies Corp
V:CNO
-0.078x
Bulletin Resources Ltd
AU:BNR
-0.046x
Eros International Media Limited
NSE:EROSMEDIA
-0.061x
Workspace Group PLC
LSE:WKP
0.018x
EA Holdings Bhd
KLSE:0154
-0.070x

Annual Cash Flow Conversion Efficiency for aXichem AB (2008–2024)

The table below shows the annual cash flow conversion efficiency of aXichem AB from 2008 to 2024. For the full company profile with market capitalisation and key ratios, see how much is aXichem AB worth.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 Skr70.16 Million
≈ $7.55 Million
Skr-11.50 Million
≈ $-1.24 Million
-0.164x +49.25%
2023-12-31 Skr48.53 Million
≈ $5.22 Million
Skr-15.68 Million
≈ $-1.69 Million
-0.323x +31.78%
2022-12-31 Skr40.33 Million
≈ $4.34 Million
Skr-19.10 Million
≈ $-2.06 Million
-0.474x -70.97%
2021-12-31 Skr56.30 Million
≈ $6.06 Million
Skr-15.60 Million
≈ $-1.68 Million
-0.277x -27.08%
2020-12-31 Skr53.65 Million
≈ $5.77 Million
Skr-11.69 Million
≈ $-1.26 Million
-0.218x -19.06%
2019-12-31 Skr67.15 Million
≈ $7.23 Million
Skr-12.29 Million
≈ $-1.32 Million
-0.183x +28.60%
2018-12-31 Skr29.10 Million
≈ $3.13 Million
Skr-7.46 Million
≈ $-802.92K
-0.256x -12.93%
2017-12-31 Skr33.86 Million
≈ $3.64 Million
Skr-7.69 Million
≈ $-827.35K
-0.227x -69.82%
2016-12-31 Skr41.33 Million
≈ $4.45 Million
Skr-5.53 Million
≈ $-594.69K
-0.134x +55.97%
2015-12-31 Skr26.27 Million
≈ $2.83 Million
Skr-7.98 Million
≈ $-858.45K
-0.304x +36.22%
2014-12-31 Skr18.93 Million
≈ $2.04 Million
Skr-9.01 Million
≈ $-970.05K
-0.476x -176.29%
2013-12-31 Skr24.92 Million
≈ $2.68 Million
Skr-4.29 Million
≈ $-462.10K
-0.172x +71.74%
2012-12-31 Skr8.01 Million
≈ $862.30K
Skr-4.89 Million
≈ $-525.79K
-0.610x -1199.16%
2011-12-31 Skr9.13 Million
≈ $982.51K
Skr-428.50K
≈ $-46.11K
-0.047x +86.41%
2010-12-31 Skr3.28 Million
≈ $352.46K
Skr-1.13 Million
≈ $-121.77K
-0.345x +34.91%
2009-12-31 Skr5.65 Million
≈ $607.93K
Skr-3.00 Million
≈ $-322.68K
-0.531x -152.73%
2008-12-31 Skr7.37 Million
≈ $792.98K
Skr7.42 Million
≈ $798.20K
1.007x --

About aXichem AB

ST:AXIC-A Sweden Specialty Chemicals
Market Cap
$8.11 Million
Skr75.37 Million SEK
Market Cap Rank
#27546 Global
#609 in Sweden
Share Price
Skr1.28
Change (1 day)
-1.16%
52-Week Range
Skr1.17 - Skr4.00
All Time High
Skr91.49
About

aXichem AB, a biotechnology company, engages in the development of natural analogue ingredients in Sweden. It offers aXivite, a natural analogue capsaicin solution for a range of dietary health applications; aXiphen-bio, a bio-repellent for antifouling protection for vessels and marine installations, pest control in agriculture and forestry, and pest control for cable installations in buildings a… Read more